Here's the short answer... If the doc can land one out of any of the deals it will give the company legitimacy. If that happens I expect the PPS will head to the $.07-.10 range in the first run. When I consider how many people are aware of this company and products in developement. I think just about anyone playing the OTC market knows about VDRM, and unfortunatly, the fact that they are unable to close a deal.
It is amazing. I am getting ready to buy now at almost a tenth of what I paid last year. The stock was supposed to rise by 10x, not reduce by 10x with shipments.